Contamination Source Identification Inc.

Hershey, PA · Founded 2018 · Medtech · Private

Genomic sequencing platform for pathogen detection and infectious disease diagnosis

New patent ·
Claim this profile

Follows are private to you and power your alerts

Updated · csidx.com

Sector
Medtech
Headquarters
Hershey, PA
Founded
2018
Latest Form D
$200K, May 2023
Total capital
$1.4M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$1.4M
3 Form D · last May 2023
42 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
2 pending · first 2026
Rank in peer group#55 of 160

Capital timeline

2020202120222023FEDERAL ↑EQUITY ↓Cumulative $2.4M1st Form D$1.2M2nd Form D$1M3rd Form D$200K
2020202120222023FEDERAL ↑EQUITY ↓Cumulative $2.4M1st Form D$1.2M2nd Form D$1M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$200K
  • Offering registeredForm D · SEC · 2nd filing$1M
  • Private capital raisedForm D · SEC · 1st filing$1.2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 160 peers

Line = median

Medtech · Instrument

  • Granted patents#55 · top 34%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Alexander J. ShopeExecutive OfficerNamed in SEC Form D filings
  • Gary J. ShopeExecutive Officer, DirectorNamed in SEC Form D filings
  • Gautam J. PatelDirectorNamed in SEC Form D filings
  • Gautem J. PatelDirectorNamed in SEC Form D filings
  • Justin J. WrightDirectorNamed in SEC Form D filings
  • Randy J. HaluckDirectorNamed in SEC Form D filings
Show all 11 people
  • Regina J. LamendellaDirectorNamed in SEC Form D filings
  • Shannon K. McCombieExecutive OfficerNamed in SEC Form D filings
  • Thomas J. SantoneDirectorNamed in SEC Form D filings
  • Timothy J. BreyaExecutive OfficerNamed in SEC Form D filings
  • Tom J. SantoneDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 3
  • Qnovia, Inc.Similar federal contract value in Medtech · null in contracts
  • Medivis, Inc.Similar federal contract value in Medtech · null in contracts
  • Atraverse Medical, Inc.Similar federal contract value in Medtech · null in contracts
  • RMR Ortho, LLCSimilar federal contract value in Medtech · null in contracts
  • EndoCellutions, Inc.Similar federal contract value in Medtech · null in contracts
  • VanDuzen, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .